MERCK Kommanditgesellschaft auf Aktien
MER
Classement en actions
#323
Globally, MERCK Kommanditgesellschaft auf Aktien conducts operations across the... Globally, MERCK Kommanditgesellschaft auf Aktien conducts operations across the healthcare, life science, and electronics sectors. The company is actively involved in the research, development, production, and commercialization of both pharmaceutical and biological prescription medications. These treatments target a range of medical conditions, including those in neurology, immunology, oncology, fertility, and cardiometabolic and endocrine disorders. Furthermore, its life science division furnishes essential products, instruments, and services to support research facilities, pharmaceutical and biotechnology manufacturing, and industrial as well as analytical testing laboratories. Within its electronics segment, MERCK supplies crucial materials for integrated circuits, liquid crystals, organic light-emitting diodes (OLEDs), photoresists, smart antenna systems, and liquid crystal glazing solutions. It also produces specialized effect pigments extensively utilized in applications such as automotive coatings, cosmetics, and various industrial and plastics manufacturing. MERCK maintains strategic partnerships with Pfizer Inc., has an agreement with Novartis AG, and holds license arrangements with Debiopharm International SA and MoonLake Immunotherapeutics AG. Established in 1668, the firm's headquarters are located in Darmstadt, Germany, and it operates as a subsidiary of E. Merck Kommanditgesellschaft.
Prix de l'action
$171.67
Dernière synchronisation: 2026-07-13
Capitalisation boursière
$74.64B
Changement (1 jour)
0.00%
Changement (1 an)
-
Pays
DE
Échange MERCK Kommanditgesellschaft auf Aktien (MER)
Catégorie
Healthcare
Bénéfices pour MERCK Kommanditgesellschaft auf Aktien (MER)
Bénéfices en 2026 TTM : 0
Selon les derniers rapports financiers de MERCK Kommanditgesellschaft auf Aktien, les bénéfices actuels de l'entreprise sont de 0. En 2026, l'entreprise a réalisé un bénéfice de 0, égal à celui de 2026 qui était de 0. Les bénéfices affichés sur cette page correspondent aux bénéfices avant intérêts et impôts, appelés aussi EBIT.
Historique des bénéfices pour MERCK Kommanditgesellschaft auf Aktien de 2002 à 2026
Bénéfices à la fin de chaque année
| Année | Bénéfices | Changez |
|---|---|---|
| 2025 | $3.88B | -15.61% |
| 2022 | $4.60B | 3.06% |
| 2021 | $4.46B | 39.31% |
| 2020 | $3.20B | 64.54% |
| 2019 | $1.95B | 15.95% |
| 2018 | $1.68B | -37.09% |
| 2017 | $2.67B | 17.75% |
| 2016 | $2.27B | 40.42% |
| 2015 | $1.61B | -14.32% |
| 2014 | $1.88B | -1.34% |
| 2013 | $1.91B | 104.18% |
| 2012 | $935.24M | -15.11% |
| 2011 | $1.10B | -4.30% |
| 2010 | $1.15B | 65.07% |
| 2009 | $697.43M | -12.95% |
| 2008 | $801.20M | -594.25% |
| 2007 | $-162.10M | -109.67% |
| 2006 | $1.68B | 58.74% |
| 2005 | $1.06B | -18.97% |
| 2004 | $1.30B | 144.81% |
| 2003 | $532.17M | 23.21% |
| 2002 | $431.92M | 0.00% |
Bénéfices des entreprises similaires ou concurrentes
| Entreprise | Bénéfices | Différence de bénéfices | Pays |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| $1.76B | - |
IN
|
|
| - | - |
CN
|
